BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 11/06/2007

FDA Proposes Removal of Essential-Use Designations for Certain Ozone-Depleting Substances in Inhalers

The FDA, in consultation with the EPA, is proposing to remove essential-use designations for certain inhalers containing ozone-depleting substances, as therapeutic alternatives without ODS are already available, providing the same public health benefits.

Source: Federal Register — Food and Drug AdministrationOpen original release →